SLC5A2 and diabetic ketoacidosis: Considering the patient’s pre-existing SGLT-2 inhibitor therapy (empagliflozin), a history of extended fasting, dehydration due to nausea and vomiting, a provisional diagnosis of euglycemic diabetic ketoacidosis under SGLT-2 inhibitor therapy was established.